The role of neutralizing antibody and T-helper subtypes in protection and pathogenesis of vaccinated mice following ocular HSV-1 challenge

Immunology

Volumn 95, Issue 3, 1998, Pages 352-359

  Ghiasi, H ^a,b   Wechsler, S L ^a,b   Cai, S ^a   Nesburn, A B ^a,b   Hofman, F M ^c  

^a CEDARS SINAI MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; NEUTRALIZING ANTIBODY; RECOMBINANT PROTEIN; RECOMBINANT PROTEIN GD; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACULOVIRUS; CELL INFILTRATION; CONTROLLED STUDY; CORNEA DISEASE; FEMALE; HELPER CELL; HERPES SIMPLEX KERATITIS; HERPES SIMPLEX VIRUS 1; INFECTION PREVENTION; INTRAPERITONEAL DRUG ADMINISTRATION; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; VACCINATION; VIRUS TITRATION;

ANIMALS; ANTIBODIES, VIRAL; BACULOVIRIDAE; CICATRIX; CORNEA; EYE; FEMALE; HERPESVIRUS 1, HUMAN; IMMUNOENZYME TECHNIQUES; KERATITIS, HERPETIC; MICE; MICE, INBRED BALB C; RABBITS; SURVIVAL RATE; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, HELPER-INDUCER; VACCINATION; VIRUS REPLICATION;

EID: 0031760956     PISSN: 00192805     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2567.1998.00602.x     Document Type: Article

References (35)

1. DAWSON C.R. & TOGNI B. (1976) Herpes simplex eye infections: clinical manifestations, pathogenesis and management. Surv Ophthalmol 21, 121.
2. DAWSON C.R. (1984) Ocular herpes simplex virus infections. Clin Dermatol 2, 56.
3. EASTY D.L., SHIMELD C., CLAOUE C.M. & MENAGE M. (1987) Herpes simplex virus isolation in chronic stromal keratitis: human and laboratory studies. Curr Eye Res 6, 69.
4. GHIASI H., WECHSLER S.L., KAIWAR R., NESBURN A.B. & HOFMAN F.M. (1995) Local expression of tumor necrosis factor alpha and interleukin-2 correlates with protection against corneal scarring after ocular challenge of vaccinated mice with herpes simplex virus type 1. J Virol 69, 334.
5. GHIASI H., KAIWAR R., NESBURN A.B., SLANINA S. & WECHSLER S.L. (1994) Expression of seven herpes simplex virus type 1 glycoproteins (gB, gC, gD, gE, gG, gH, and gI): comparative protection against lethal challenge in mice. J Virol 68, 2118.
6. HENDRICKS R.L. & TUMPEY T.M. (1990) Contribution of virus and immune factors to herpes simplex virus type I-induced corneal pathology. Invest Ophthalmol Vis Sci 31, 1929.
7. ROUSE B.T. (1996) Virus-induced immunopathology. Adv Virus Res 47, 353.
8. SHIMELD C., HILL T.J., BLYTH W.A. & EASTY D.L. (1990) Passive immunization protects the mouse eye from damage after herpes simplex virus infection by limiting spread of virus in the nervous system. J Gen Virol 71, 681.
9. MOSMANN T.R., CHERWINSKI H., BOND M.W., GIEDLIN M.A. & COFFMAN R.L. (1986) Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol 136, 2348.
10. ABBAS A.K., MURPHY K.M. & SHER A. (1996) Functional diversity of helper T lymphocytes. Nature 383, 787.
11. MARUYAMA T., SCHODEL F., IINO S. et al. (1994) Distinguishing between acute and symptomatic chronic hepatitis B virus infection. Gastroenterology 106, 1006.
12. MILICH D.R., PETERSON D.L., SCHODEL F., JONES J.E. & HUGHES J.L. (1995) Preferential recognition of hepatitis B nucleocapsid antigens by Th1 or Th2 cells is epitope and major histocompatibility complex dependent. J Virol 69, 2776.
13. GRAHAM M.B., BRACIALE V.L. & BRACIALE T.J. (1994) Influenza virus-specific CD4+ T helper type 2 T lymphocytes do not promote recovery from experimental virus infection. J Exp Med 180, 1273.
14. JAYARAMAN S., HEILIGENHAUS A., RODRIGUEZ A., SOUKIASIAN S., DORF M.E. & FOSTER C.S. (1993) Exacerbation of murine herpes simplex virus-mediated stromal keratitis by Th2 type T cells. J Immunol 151, 5777.
15. HEILIGENHAUS A., JAYARAMAN S., SOUKIASIAN S., DORF M. & FOSTER C.S. (1995) Glycoprotein D (5) specific Th2-T-cell line induces HSV-1 keratitis. Ophthalmologe 92, 484.
16. CARMACK M.A., YASUKAWA L.L., CHANG S.Y. et al. (1996) T cell recognition and cytokine production elicited by common and type- specific glycoproteins of herpes simplex virus type 1 and type 2. J Infect Dis 174, 899.
17. MANICKAN E., KANANGAT S., ROUSE R.J., YU Z. & ROUSE B.T. (1997) Enhancement of immune response to naked DNA vaccine by immunization with transfected dendritic cells. J Leukoc Biol 61, 125.
18. BABU J.S., KANANGAT S. & ROUSE B.T. (1995) T cell cytokine mRNA expression during the course of the immunopathologic ocular disease herpetic stromal keratitis. J Immunol 154, 4822.
19. NIEMIALTOWSKI M.G. & ROUSE B.T. (1992) Predominance of Th1 cells in ocular tissues during herpetic stromal keratitis. J Immunol 149, 3035.
20. WECHSLER S.L., NESBURN A.B., WATSON R., SLANINA S. & GHIASI H. (1988) Fine mapping of the major latency-related RNA of herpes simplex virus type 1 in humans. J Gen Virol 69, 3101.
21. GHIASI H., BAHRI S., NESBURN A.B. & WECHSLER S.L. (1995) Protection against herpes simplex virus-induced eye disease after vaccination with seven individually expressed herpes simplex virus 1 glycoproteins. Invest Ophthalmol Vis Sci 36, 1352.
22. DUCHINI A., GOVINDARAJAN S., SANTUCCI M., ZAMPI G. & HOFMAN F.M. (1996) Effects of tumor necrosis factor-alpha and interleukin-6 on fluid-phase permeability and ammonia diffusion in CNS-derived endothelial cells. J Invest Med 44, 474.
23. GHIASI H., CAI S., NESBURN A.B. & WECHSLER S.L. (1996) Vaccination with herpes simplex virus type 1 glycoprotein K impairs clearance of virus from the trigeminal ganglia resulting in chronic infection. Virology 224, 330.
24. SHIMELD C., WHITELAND J.L., NICHOLLS S.M., EASTY D.L. & HILL T.J. (1996) Immune cell infiltration in corneas of mice with recurrent herpes simplex virus disease. J Gen Virol 77, 977.
25. METCALF J.F. & KAUFMAN H.E. (1976) Herpetic stromal keratitis-evidence for cell-mediated immunopathogenesis. Am J Ophthalmol 82, 827.
26. DOYMAZ M.Z., FOSTER C.M., DESTEPHANO D. & ROUSE B.T. (1991) MHC II-restricted, CD4+ cytotoxic T lymphocytes specific for herpes simplex virus-1: implications for the development of herpetic stromal keratitis in mice. Clin Immunol Immunopathol 61, 398.
27. BASS H., MOSMANN T. & STROBER S. (1989) Evidence for mouse Th1- and Th2-like helper T cells in vivo. Selective reduction of Th1-like cells after total lymphoid irradiation. J Exp Med 170, 1495.
28. BIRON C.A. (1994) Cytokines in the generation of immune responses to, and resolution of, virus infection. Curr Opin Immunol 6, 530.
29. WYNN T.A. & CHEEVER A.W. (1995) Cytokine regulation of granuloma formation in schistosomiasis. Curr Opin Immunol 7, 505.
30. NESBURN A.B. (1975) Recurrence in ocular herpes simplex infection. Int Ophthalmol Clin 15, 101.
31. BERKOWITZ C. & BECKER Y. (1992) Recombinant interleukin-1 alpha, interleukin-2 and M-CSF-1 enhance the survival of newborn C57BL/6 mice inoculated intraperitoneally with a lethal dose of herpes simplex virus-1. Arch Virol 124, 83.
32. ROSSOL-VOTH R., ROSSOL S., SCHUTT K.H., CORRIDORI S., DE CIAN W. & FALKE D. (1991) In vivo protective effect of tumour necrosis factor alpha against experimental infection with herpes simplex virus type 1. J Gen Virol 72, 143.
33. MORAN T.M., ISOBE H., FERNANDEZ-SESMA A. & SCHULMAN J.L. (1996) Interleukin-4 causes delayed virus clearance in influenza virus- infected mice. J Virol 70, 5230.
34. PEARLMAN E., LASS J.H., BARDENSTEIN D.S. et al. (1995) Interleukin 4 and T helper type 2 cells are required for development of experimental onchocercal keratitis (river blindness). J Exp Med 182, 931.
35. CHEEVER A.W., WILLIAMS M.E., WYNN T.A. et al. (1994) Anti-IL-4 treatment of Schistosoma mansoni-infected mice inhibits development of T cells and non-B, non-T cells expressing Th2 cytokines while decreasing egg-induced hepatic fibrosis. J Immunol 153, 753.